Home › Funds › Destination Wealth Management › ABT

Destination Wealth Management position in ABT

ABBOTT LABORATORIES · Health Care

Destination Wealth Management reported holding 279,515 shares of ABT (ABBOTT LABORATORIES) in its Q2 2026 13F filing — a position valued at US$25.4M, representing 0.69% of its reported portfolio and ranking #44 among its reported holdings. Destination Wealth Management has disclosed ABT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)279.51K sh
Reported value held$25.36M
Portfolio Weight0.69%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Destination Wealth Management's ABT position evolved

Destination Wealth Management first disclosed a stake in ABT in Q3 2023 at 235,697 shares (US$22.8M). The position peaked in Q2 2025 at 240,915 shares, worth US$32.8M. Across 12 filings, Destination Wealth Management increased the stake 8 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 279,515 shares valued at US$25.4M — an increase of 22,421 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 235.70K $22.83M New
Q4 2023 233.13K $25.66M Reduce
Q1 2024 234.94K $26.70M Add
Q2 2024 237.26K $24.65M Add
Q3 2024 240.82K $27.46M Add
Q4 2024 242.46K $27.42M Add
Q1 2025 241.52K $32.04M Hold
Q2 2025 240.91K $32.77M Hold
Q3 2025 242.53K $32.49M Add
Q4 2025 245.22K $30.72M Add
Q1 2026 257.09K $26.40M Add
Q2 2026 279.51K $25.36M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Destination Wealth Management held ABT?

Destination Wealth Management has disclosed ABT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Destination Wealth Management's current position in ABT?

As of Q2 2026, Destination Wealth Management holds 279.51K shares of ABT (ABBOTT LABORATORIES), valued at $25.36M, representing 0.69% of its reported portfolio and ranking #44.

Has Destination Wealth Management been buying or selling ABT?

In the latest 13F filing (Q2 2026), Destination Wealth Management increased its position in ABT. The position peaked in Q2 2025 at 240.91K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.